Authors

• Niko Beerenwinkel (ORCID: https://orcid.org/0000-0002-0573-6119)
• Jennifer Giandhari (ORCID: https://orcid.org/0000-0002-2944-4583)
• Stefanie Hossmann (ORCID: https://orcid.org/0000-0003-1600-5925)
• Richard Lessells (ORCID: https://orcid.org/0000-0003-0926-710X)
• Albert Kla Minga (ORCID: https://orcid.org/0000-0003-2357-6902)
• Antoine Jaquet (ORCID: https://orcid.org/0000-0002-3426-9492)
• Jeremy L. Ross (ORCID: https://orcid.org/0000-0003-3183-2451)
• Roger D. Kouyos (ORCID: https://orcid.org/0000-0002-9220-8348)
• Tom Loosli (ORCID: https://orcid.org/0000-0003-2049-3562)
• Matthias Egger (ORCID: https://orcid.org/0000-0001-7462-5132)
• Mamatha Sauermann
• Selma Riedo

Institutions

• University of Bern (CH)
• Western Cape Department of Health (ZA)
• Université de Bordeaux (FR)
• Inserm (FR)
• University of Cape Town (ZA)
• University of Zurich (CH)
• Centre for the AIDS Programme of Research in South Africa (ZA)
• ETH Zurich (CH)
• University Hospital of Zurich (CH)
• Bordeaux Population Health (FR)
• Société de Développement des Forêts (CI)
• Institute of Social and Preventive Medicine (CH)
• Wellcome Centre for Infectious Diseases Research in Africa (ZA)
• Institut de Recherche pour le Développement (FR)
• University of KwaZulu-Natal (ZA)

Publication Details

Journal

BMJ Open

Published

2024-08-01

DOI

https://doi.org/10.1136/bmjopen-2024-085819

Citations

5

Primary Topic

HIV/AIDS drug development and treatment

Type

article

Field-Weighted Citation Impact

1.95

Funders

• National Science Foundation
• Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
• Inyuvesi Yakwazulu-Natali
• National Institutes of Health
• National Institute of Mental Health
• National Cancer Institute
• National Institute of Allergy and Infectious Diseases
• National Institute of Child Health and Human Development
• Eunice Kennedy Shriver National Institute of Child Health and Human Development